# Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

> **NCT04521790** · — · RECRUITING · sponsor: **Scientific Institute San Raffaele** · enrollment: 1000 (estimated)

## Conditions studied

- Myocarditis
- Ventricular Arrythmia
- Inflammatory Cardiomyopathy
- Genetic Predisposition
- Autoimmunity
- Arrhythmia
- Cardiomyopathies
- Immunosuppression
- Catheter Ablation

## Interventions

- **OTHER:** support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation

## Key facts

- **NCT ID:** NCT04521790
- **Lead sponsor:** Scientific Institute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04521790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04521790, "Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04521790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*